小分子和化合物库

选项
视图 列表 网格

显示第112个,产品总数165

设置降序方向
  1. NF023,竞争性P2X 1受体拮抗剂
      规格或纯度 :
    • ≥94%
    CAS号: 104869-31-0
    分子式: C35H20N4Na6O21S6·12·5H2O        分子量: 1388.02
    SMILES: C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(=O)NC3=C4C(=CC(=CC4=C(C=C3)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C(=O)NC5=C6C(=CC(=CC6=C(C=C5)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O.[Na].[Na].[Na].[Na].[Na].[Na]
    InChIKey: GKOOKWDOKJAVBD-UHFFFAOYSA-N
    InChI: 1S/C35H26N4O21S6.6Na/c40-33(38-25-7-9-27(63(49,50)51)23-13-21(61(43,44)45)15-29(31(23)25)65(55,56)57)17-3-1-5-19(11-17)36-35(42)37-20-6-2-4-18(12-20)34(41)39-26-8-10-28(64(52,53)54)24-14-22(62(46,47)4See more
  2. NYC-488,新型钙蛋白酶抑制剂
      规格或纯度 :
    • ≥94%
    CAS号: 1448429-06-8        Compound CID : 71660816
    分子式: C19H17FN6O5S        分子量: 460.4
    IUPAC Name: (2S,3S)-3-[[(2S)-1-[[1-(4-fluorophenyl)triazol-4-yl]methylamino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]carbamoyl]oxirane-2-carboxylic acid
    SMILES: C1=CC(=CC=C1N2C=C(N=N2)CNC(=O)C(CC3=CSC=N3)NC(=O)C4C(O4)C(=O)O)F
    InChIKey: IPWMYOJQVHCYRC-JYJNAYRXSA-N
    InChI: 1S/C19H17FN6O5S/c20-10-1-3-13(4-2-10)26-7-12(24-25-26)6-21-17(27)14(5-11-8-32-9-22-11)23-18(28)15-16(31-15)19(29)30/h1-4,7-9,14-16H,5-6H2,(H,21,27)(H,23,28)(H,29,30)/t14-,15-,16-/m0/s1
  3. (1R,1'S,3'R/1R,1'R,3'S)-L-054,264
      规格或纯度 :
    • ≥94%
    CAS号: 208706-12-1        Compound CID : 9915239
    分子式: C33H41N5O2        分子量: 539.71
    IUPAC Name: N-[(2R)-1-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methylamino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]spiro[indene-1,4'-piperidine]-1'-carboxamide
    SMILES: C1CC(CC(C1)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)N4CCC5(CC4)C=CC6=CC=CC=C56)CN
    InChIKey: DAMXHAMKVXERLM-FVBCXUTKSA-N
    InChI: 1S/C33H41N5O2/c34-20-23-6-5-7-24(18-23)21-36-31(39)30(19-26-22-35-29-11-4-2-9-27(26)29)37-32(40)38-16-14-33(15-17-38)13-12-25-8-1-3-10-28(25)33/h1-4,8-13,22-24,30,35H,5-7,14-21,34H2,(H,36,39)(H,37,40)See more
  4. CP 1282
      规格或纯度 :
    • ≥94%
    CAS号: 69712-30-7        Compound CID : 155329
    分子式: C17H17N7O8S4        分子量: 575.62
    IUPAC Name: (6R,7S)-7-[[2-[(4-carboxy-3-oxo-1,2-thiazol-5-yl)sulfanyl]acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
    SMILES: CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSC4=C(C(=O)NS4)C(=O)O)OC)SC2)C(=O)O
    InChIKey: WCUINLYXNAJTNU-WBVHZDCISA-N
    InChI: 1S/C17H17N7O8S4/c1-23-16(19-21-22-23)35-4-6-3-34-15-17(32-2,14(31)24(15)9(6)12(29)30)18-7(25)5-33-13-8(11(27)28)10(26)20-36-13/h15H,3-5H2,1-2H3,(H,18,25)(H,20,26)(H,27,28)(H,29,30)/t15-,17+/m1/s1
每页